|
|
|
|
||
Amgen’s KRAS-blocking drug shows minimal effectAmgen’s KRAS-blocking drug shows minimal effect in colon cancer patients ..May be TILSO can help here and IDRA starting the MSS-CRC trial news on Monday with the news of AMgen's failure ( which is not good for patients) will be noticed by everyone .. https://www.statnews.com/2019/09/28/amgens-kras-blocking-drug-shows-minimal-effect-in-colon-cancer-patients/ MSS-CRC |
return to message board, top of board |